A 39-year-old Pennsylvania woman was admitted at term for delivery in 1997. She was managed by a certified nurse midwife and obstetrician and after 8 hours of labor the infant was delivered by cesarean section. He had no heart rate, and was pale and limp. Despite resuscitation, when a neonatologist arrived 11 minutes later, the infant was subsequently diagnosed with cerebral palsy with global developmental delay and quadriplegia.
A 39-year-old Pennsylvania woman was admitted at term for delivery in 1997. She was managed by a certified nurse midwife and obstetrician and after 8 hours of labor the infant was delivered by cesarean section. He had no heart rate, and was pale and limp. Despite resuscitation, when a neonatologist arrived 11 minutes later, the infant was subsequently diagnosed with cerebral palsy with global developmental delay and quadriplegia.
A lawsuit filed against those involved with the delivery claimed that the labor was allowed to continue despite significant abnormalities in the FHR, that a C/S should have been performed earlier, and that it was negligent not to have a specialist present at a delivery in which it took 11 minutes for a neonatologist to resuscitate the infant. Just prior to the beginning of the trial, the defendants all conceded liability and the case went ahead on the issue of damages. A jury awarded $57.6 million on behalf of the child. The parties had reached a high/low agreement prior to the verdict with an agreement of $10 million if it was a defense verdict and $23 million if the verdict was for the plaintiff.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More